|
Name |
Methyl heptadecanoate
|
Molecular Formula | C18H36O2 | |
IUPAC Name* |
methyl heptadecanoate
|
|
SMILES |
CCCCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C18H36O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20-2/h3-17H2,1-2H3
|
|
InChIKey |
HUEBIMLTDXKIPR-UHFFFAOYSA-N
|
|
Synonyms |
METHYL HEPTADECANOATE; 1731-92-6; Methyl margarate; Heptadecanoic acid, methyl ester; Margaric acid methyl ester; Heptadecanoic acid methyl ester; methylheptadecanoate; 41PZK7H0KL; n-Heptadecanoic acid methyl ester; Heptadecanoic Acid Methyl Ester,(S); NSC-97364; WE(1:0/17:0); UNII-41PZK7H0KL; Heptadecanoic acid,methyl ester; EINECS 217-055-3; formyl heptadecanoate; MFCD00009001; NSC 97364; AI3-36453; Heptadecanoic acid methyl; Methyl heptadecanoate, 95%; Methyl heptadecanoate, 99%; SCHEMBL346760; Heptadecanoic acid-methyl ester; Methyl heptadecanoate, >=99%; DTXSID3061924; CDAA-251017M; CHEBI:136920; ALBB-025070; NSC97364; LMFA07010473; ZINC62238196; AKOS015903907; CS-W004290; HY-W004290; AS-49344; Methyl heptadecanoate, analytical standard; FT-0726048; H0566; H10839; Methyl heptadecanoate, purum, >=95.0% (GC); B6629AC7-DDCA-4BCF-AFB1-744D9D2EE8F5; Q24735110; Methyl heptadecanoate, certified reference material, TraceCERT(R)
|
|
CAS | 1731-92-6 | |
PubChem CID | 15609 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.5 | ALogp: | 8.5 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.269 |
Caco-2 Permeability: | -4.818 | MDCK Permeability: | 0.00001500 |
Pgp-inhibitor: | 0.014 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.977 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.267 | Plasma Protein Binding (PPB): | 97.29% |
Volume Distribution (VD): | 2.345 | Fu: | 1.46% |
CYP1A2-inhibitor: | 0.442 | CYP1A2-substrate: | 0.201 |
CYP2C19-inhibitor: | 0.423 | CYP2C19-substrate: | 0.078 |
CYP2C9-inhibitor: | 0.18 | CYP2C9-substrate: | 0.945 |
CYP2D6-inhibitor: | 0.165 | CYP2D6-substrate: | 0.058 |
CYP3A4-inhibitor: | 0.357 | CYP3A4-substrate: | 0.058 |
Clearance (CL): | 4.864 | Half-life (T1/2): | 0.237 |
hERG Blockers: | 0.269 | Human Hepatotoxicity (H-HT): | 0.026 |
Drug-inuced Liver Injury (DILI): | 0.351 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.957 | Carcinogencity: | 0.056 |
Eye Corrosion: | 0.952 | Eye Irritation: | 0.968 |
Respiratory Toxicity: | 0.907 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000280 | 0.950 | D07ILQ | 0.671 | ||||
ENC000271 | 0.947 | D0Z5SM | 0.563 | ||||
ENC000497 | 0.905 | D00FGR | 0.553 | ||||
ENC000560 | 0.895 | D00AOJ | 0.550 | ||||
ENC000474 | 0.864 | D0O1PH | 0.500 | ||||
ENC000604 | 0.842 | D05ATI | 0.486 | ||||
ENC000575 | 0.828 | D00MLW | 0.410 | ||||
ENC000419 | 0.810 | D00STJ | 0.402 | ||||
ENC000464 | 0.792 | D0T9TJ | 0.384 | ||||
ENC000258 | 0.791 | D0P1RL | 0.376 |